Abstract:AIMS Endothelial cell (EC) homeostasis plays an important role in normal physiological cardiac functions, and its dysfunction significantly influences pathological cardiac remodeling after myocardial infarction (MI). It has been shown that the sphingosine 1-phospahte receptor 1 (S1pr1) was highly expressed in ECs and played an important role in maintaining endothelial functions. We thus hypothesized that the endothelial S1pr1 might be involved in post-MI cardiac remodeling. METHODS AND RESULTS Our study showed that the specific loss of endothelial S1pr1 exacerbated post-MI cardiac remodeling and worsened cardiac dysfunction. We found that the loss of endothelial S1pr1 significantly reduced Ly6clow macrophage accumulation, which is critical for the resolution of inflammation and cardiac healing following MI. The reduced reparative macrophages in post-MI myocardium contributed to the detrimental effects of endothelial S1pr1 deficiency on post-MI cardiac remodeling. Further investigations showed that the loss of endothelial S1pr1 reduced Ly6clow macrophage proliferation, while the pharmacological activation of S1pr1 enhanced Ly6clow macrophage proliferation and thereby ameliorated cardiac remodeling after MI. A mechanism study showed that S1P/S1pr1 activated the ERK signaling pathway and enhanced colony stimulating factor 1 (CSF1) expression, which promoted Ly6clow macrophage proliferation in a cell-contact manner. The blockade of CSF1 signaling reversed the enhancing effect of S1pr1 activation on Ly6clow macrophage proliferation and worsened post-MI cardiac remodeling. CONCLUSIONS This study reveals that cardiac microvascular endothelium promotes reparative macrophage proliferation in injured hearts via the S1P/S1PR1/ERK/CSF1 pathway and thus ameliorates post-MI adverse cardiac remodeling. TRANSLATIONAL PERSPECTIVE This study highlights the importance of the local vascular microenvironment in orchestrating tissue inflammation and remodeling by regulating self-replenishment of tissue local reparative macrophages. Our studies demonstrate that ECs tightly control post-MI reparative Mo/Mϕ proliferation via the S1P/S1PR1/CSF1 pathway in a cell-contact manner. This implies that a feasible modulation of vascular niche signals might provide a promising target to resolve excessive inflammation and to ameliorate adverse cardiac remodeling after MI.

The Characteristic of Resident Macrophages and Their Therapeutic Potential for Myocardial Infarction

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches

Macrophage-driven Cardiac Inflammation and Healing: Insights from Homeostasis and Myocardial Infarction

New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction

Genetically Engineered Macrophages Co-Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury

Macrophage‐mediated heart repair and remodeling: A promising therapeutic target for post‐myocardial infarction heart failure

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Regulatory T Lymphocytes in Myocardial Infarction: A Promising New Therapeutic Target

Resident macrophages as potential therapeutic targets for cardiac ageing and injury

Recent advances in potential targets for myocardial ischemia reperfusion injury: Role of macrophages

At the heart of inflammation: Unravelling cardiac resident macrophage biology

Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction

Cardiac resident macrophages: Spatiotemporal distribution, development, physiological functions, and their translational potential on cardiac diseases

CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury

Targeted Treatment of Myocardial Infarction by Macrophage Membrane Coated with Resveratrol Nanoparticles

Advances in macrophage metabolic reprogramming in myocardial ischemia-reperfusion

Vascular Endothelial S1pr1 Ameliorates Adverse Cardiac Remodelling Via Stimulating Reparative Macrophage Proliferation after Myocardial Infarction.

Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia